Introduction
The signaling pathways that control the life and death of a cell are of prime interest in modern biology. Mutations affecting components of these pathways are often implicated in diseases arising from too much or too little apoptosis, such as neurodegeneration and cancer. The vertebrate Rel/NF-kB transcription factors are critical players in the control of the apoptotic response to a variety of stimuli. They are best known for their pivotal roles in immune, inflammatory and acute phase responses, but they also play important roles in cell growth, apoptosis and oncogenesis (reviewed in Silverman and Maniatis, 2001; Karin and Lin, 2002; Li and Verma, 2002) .
The Rel/NF-kB family is comprised of the vertebrate c-Rel, RelA, RelB, p105/NF-kB1 and p100/NF-kB2 proteins, the viral oncoprotein v-Rel, Xenopus X-Rel1, and the Drosophila Dorsal, Dif and Relish factors. These structurally related proteins share extensive sequence similarity in their N-terminal Rel homology domain (RHD) that enables them to translocate to the nucleus, form dimers with one another and bind to kB DNA sites (GGGRNNYYCC). The distinct C-terminal ends of vertebrate Rel/NF-kB factors participate in transcriptional activation (v-Rel, c-Rel, RelA, RelB) or in the control of Rel protein activity (p105/NF-kB1, p100/NF-kB2). The latter group shares homology with the IkB family of Rel protein regulators that control their subcellular localization and inhibit their DNAbinding activity (IkBa, IkBb, IkBe, .
Studies in recent years have provided important insights into the pathways that lead to NF-kB activation (reviewed in Karin and Ben-Neriah, 2000) . In most cells, Rel/NF-kB subunits are sequestered in the cytoplasm as inactive homo-or heterodimers, bound to one of several IkB factors. The rapid and transient activation of NF-kB complexes in response to a wide variety of stimuli generally involves phosphorylation of IkB by the IkB kinase complex (IKK), which contains the catalytic subunits IKKa and IKKb and the regulatory IKKg/NEMO protein. Phosphorylation targets IkB for degradation via the ubiquitinproteasome pathway and culminates in the nuclear translocation of active Rel/NF-kB dimers, their binding to DNA and the transcriptional activation of cellular genes involved in immune responses, inflammation, viral infection, cell proliferation and survival. In turn, nuclear NF-kB factors trigger the resynthesis of IkBa, giving rise to an autoregulatory loop that terminates the activation process. Phosphorylate IkBa to promote its degradation (Schwarz et al., 1996; Miyamoto et al., 1998; Romieu-Mourez et al., 2001; Shen et al., 2001; Kato et al., 2003) . In addition to the classical NF-kB signaling pathway, a noncanonical NF-kB cascade has been identified to involve signaling via the NF-kBinducing kinase (NIK) and IKKa, and results in the processing of p100/NF-kB2 to mature p52/NF-kB2 (Senftleben et al., 2001; Xiao et al., 2001) . Hundreds of NF-kB-regulated genes have been identified (reviewed in Pahl, 1999) . While it is clear that the particular combination of NF-kB subunits within distinct NF-kB homo-or heterodimers is in a large part responsible for determining the subsets of genes that they activate, a recent study has added a new dimension to this concept. Experiments with cell lines deficient for single or multiple NF-kB subunits revealed that the in vivo specificity of cellular gene activation does not only lie within the sequence of the kB DNA site, but is also likely to be greatly influenced by combinatorial proteinprotein interactions with other promoter-bound factors . This additional level of regulation is likely to help determine the specificity of gene activation to ensure a differential response to different stimuli.
The last few years have seen a virtual explosion in the number of studies investigating the role of NF-kB in apoptosis in different systems, and important progress was made in understanding the mechanisms involved. Here, we review the pro-and antiapoptotic effects of NF-kB, its important involvement in different physiological contexts, the mechanisms by which it operates and those that regulate its activity.
Lessons in survival: studies of NF-kB's pro-and antiapoptotic functions in knockout mice and model cell systems All five members of the mammalian Rel/NF-kB family and several components of the NF-kB signaling pathway have been targeted by homozygous inactivation in mice to characterize their function. The phenotypes of these animals have been reviewed in detail (reviewed in Li and Verma, 2002) . These studies revealed distinct roles for individual NF-kB subunits in innate and adaptive immune responses, and also unveiled a pivotal role for NF-kB in regulating apoptosis in the immune and nervous systems, in the liver, and in hair follicles and epidermal appendages. This section focuses on those that revealed a link to apoptosis, on studies in in vitro cell systems that support these findings and emphasizes recent discoveries that shed further light on the subject.
NF-kB: life and death decisions in the immune system
A protective role for NF-kB in B cells The survival of peripheral B cells in response to antigen depends on Bcell receptor (BCR)-mediated activation of NF-kB and the induction of antiapoptotic target genes. Early studies in B-lymphocyte cell lines demonstrated a vital role for NF-kB in this process, as suppression of endogenous NF-kB activity invariably led to apoptosis in cells treated with anti-IgM antibodies, whereas ectopic expression of c-rel restored viability (Wu et al., 1996a, b) . Consistent with these findings, primary B cells from c-rel-deficient mice undergo apoptosis upon mitogenic stimulation, and this phenotype is rescued by transgenes encoding c-Rel itself, or its antiapoptotic targets Bcl-2, Bcl-xL or Bfl-1/A1 (Kontgen et al., 1995; Grumont et al., 1998 Grumont et al., , 1999 Tumang et al., 1998; Owyang et al., 2001) . Whereas p50/NF-kB1 is important for the survival of quiescent B cells, combined inactivation of p50 and c-rel in double knockout mice established a critical role for these factors in mitogenactivated B cells (Grumont et al., 1998) . The pathway leading to NF-kB activation in response to BCR engagement has been elucidated ( Figure 1A ). As anticipated, inactivation of individual components of this cascade, including B-lineage-specific depletion of IKKb or IKKg/NEMO, results in dramatic inhibition of NF-kB stimulation following BCR engagement and increased apoptosis (Petro et al., 2000; Leitges et al., 2001; Petro and Khan, 2001; Tan et al., 2001; Martin et al., 2002; Pasparakis et al., 2002b; Li et al., 2003) . In some of these studies, this was correlated with a failure to induce expression of antiapoptotic proteins Bcl-xL and Bcl-2.
Contrary to the single knockouts of c-rel or relA, B cells from compound c-rel/relA double knockout embryos fail to mature to the IgM(lo)IgD(hi) stage due to premature death by apoptosis, coincident with impaired expression of Bcl-2 and Bfl-1/A1 (Grossmann et al., 2000) . A bcl-2 transgene could rescue this phenotype. In contrast, expression of a bcl-xl transgene into bone marrow cells transduced with a transdominant form of IkBa could not surmount the impairment for maturation to follicular B cells in recipient mice, although it restored viability to pre-B/immature B-cell subsets (HC Liou, personal communication) . Together, these results emphasize an important role for individual NF-kB subunits in B-cell survival, maturation and function.
NF-kB has also been implicated in attenuating apoptosis in response to the cytokine BAFF (also known as BlyS), which is necessary for peripheral B-cell development, as illustrated by the phenotype of mice expressing nonfunctional BAFF receptor (BAFF-R) or lacking BAFF (Schiemann et al., 2001) . Recent studies showed that in quiescent B cells, BAFF activates NF-kB through both the classical and the noncanonical NF-kB pathways, with predominance for the latter ( Figure 1A ; Kayagaki et al., 2002; Hatada et al., 2003) . Whereas binding of BAFF to BAFF receptor 3 (BR3) leads to processing of p100/NFkB2 to p52, one study revealed a requirement for the NF-kB subunit of p50 for the survival function of BAFF (Hatada et al., 2003) . As a consequence of BAFF-mediated NF-kB activation, antiapoptotic genes encoding Bcl-2, Bcl-xL and Bfl-1/A1 are activated, but only in mature B cells (Do et al., 2000; Hsu et al., 2002) .
Anti-and proapoptotic roles for NF-kB in T cells
The full activation of naı¨ve T cells requires engagement of the T-cell receptor (TCR) and costimulatory signaling by CD28. This leads to NF-kB activation and consequent cell survival via induction of antiapoptotic genes, and to proliferation via synthesis of IL-2 and GM-CSF. Studies with wild-type and p50
þ T cells demonstrated that activation of NF-kB following TCR engagement in conjunction with CD28 costimulation is critically required to induce expression of antiapoptotic genes bcl-xl and bcl-2 and promote Tcell viability (Zheng et al., 2003) . Similar results were observed in CD4 þ T cells expressing a super-repressor form of IkBa (Khoshnan et al., 2000) . Whereas cessation of TCR stimulation in wild-type T cells caused a rapid drop in endogenous NF-kB levels along with apoptosis, enforced expression of IKKb enabled cells to survive in the absence of sustained TCR stimulation (Zheng et al., 2003) . A recent analysis of activated CD4 þ or CD8 þ T cells indicated that while induction of the NF-kB targets Bcl-xL and its homologue Bfl-1/A1 is transient, that of Bcl-2 is delayed and IL-2 dependent (Verschelde et al., 2003) .
In the absence of CD28-derived costimulatory signals, apoptosis of antigenically stimulated naı¨ve T cells can be inhibited in vivo by adjuvant-induced inflammation. Microarray analyses revealed that sustained T cell response in a model of adjuvant-induced survival was correlated with increased expression of the IkB-related Bcl-3 protein (Mitchell et al., 2002a) . Retroviralmediated transfer of Bcl-3 itself or a subdomain containing its first and second ankyrin repeats could confer survival to activated T cells in vitro and in vivo (Mitchell et al., 2001 (Mitchell et al., , 2002b . Unlike other IkB molecules, Bcl-3 is generally found in the nucleus where it modulates transcription via interaction with homodimers of p50/NF-kB1 or p52/NF-kB2. It was thus postulated that Bcl-3 might enhance cell viability in this context by inducing the expression of NF-kB-regulated genes. These results reveal a mechanism underlying the protective effects of inflammation and innate immunity toward T-cell apoptosis in the adaptive immune response (reviewed in Gerondakis and Strasser, 2001) .
A recently published report has unveiled a new way for NF-kB to antagonize cell death in antigenically stimulated naı¨ve T cells in the absence of costimulatory Figure 1 NF-kB activation in adaptative and innate immune responses (A) B-cell activation triggers the NF-kB signaling pathway in the adaptive immune response. (a) BCR activation by antigen leads to the recruitment of a functional complex containing Syk, Btk, BLNK and PLC-g2. Activation of PLC-g2 provokes the release of calcium and diacylglycerol to activate PKC-b and induce both the classical and noncanonical NF-kB pathways via phosphorylation of IKKa and IKKb. Both pathways lead to the activation of NF-kBresponsive genes. Contrary to PKC-b, PKC-z does not activate NF-kB via IKK, but rather directly phosphorylates RelA to enhance its transcriptional activity. (b) BAFF signaling in B cells induces the noncanonical NF-kB pathway. BAFF-R engagement leads to the activation of NIK that phosphorylates and activates IKKa. In turn, IKKa phosphorylates p100/NF-kB2 in an IKKg/NEMOindependent manner. This initiates ubiquitin-mediated proteolytic processing of p100 to p52. Formation of p52 heterodimers with RelB results in NF-kB-dependent gene activation. (B) Engagement of cell surface TLRs and cytosolic NOD receptors activates NF-kB signaling in the innate immune response. (a) The binding of bacterial LPS to TLR4 triggers recruitment of MyD88 and the serine/ threonine kinase IRAK, leading to its association with adaptor protein TRAF6 and MAP3K. This intracellular signaling cascade converges on activation of the IKK kinase complex and NF-kB to induce gene expression. (b) Ligands such as MDP, released following phagocytosis of bacteria, are recognized by cytosolic NOD receptors. Activation of some NODs can induce two different signaling pathways. One pathway activates the classical NF-kB signaling cascade in a RICK-and RIP-dependent manner, resulting in NF-kB-dependent expression of proinflammatory cytokines, and in the case of NOD2 of prosurvival factor Bfl-1/A1. The other pathway leads to caspase activation and cell death signal, that is, by suppressing expression of the p53-related p73 protein (Wan and DeGregori, 2003) . In this study, inhibition of NF-kB in T cells by a superrepressor form of IkBa triggered E2F-and p73-dependent apoptosis upon cell activation. In contrast, cells lacking p73 survived despite inhibition of NF-kB. The mechanism by which NF-kB downregulates p73 remains to be clarified, but the presence of putative NFkB binding sites in the vicinity of p73's first exon gave rise to speculation that NF-kB might interfere with E2F-mediated transactivation of p73. This study is consistent with prior work implicating E2F1 and p73 in inducing apoptosis in activated mature T cells (reviewed in Green, 2003) . This newly uncovered interplay between NF-kB and the Cdk-Rb-E2F pathway to control the outcome of T cells following receptor engagement suggests that in the absence of costimulatory signal to activate NF-kB, E2F-mediated induction of p73 could perhaps serve to eliminate autoreactive T cells from the peripheral repertoire (reviewed in Green, 2003) . These results provide new insights into the role of NF-kB in the survival of antigen-stimulated naı¨ve T cells.
In contrast to the antiapoptotic activity of NF-kB described above, others showed that NF-kB contributes to apoptosis during activation-induced cell death (AICD) in mature T cells. In this context, NF-kB triggered the Fas-death cascade by directly activating the expression of Fas ligand (FasL) ( Duyao et al. (1990) , La Rosa et al. (1994) et al., 1999; Lin et al., 1999; Zheng et al., 2001) . The expression of a dominant IkB molecule (IkBaM) inhibited both FasL expression and apoptosis. However, it remains to be determined how this pathway of AICD relates to that involving Cdk-Rb-E2F and p73 described above.
The protective role of NF-kB during T-cell development is also a subject of debate. Studies indicate that NF-kB is required for the survival of developing thymocytes, as pre-T cells in which NF-kB expression was abolished undergo spontaneous apoptosis, whereas a constitutively active form of IKK allowed cells to differentiate to the CD4 þ CD8 þ double-positive stage (Voll et al., 2000) . This agrees with the impaired thymocyte development observed in transgenic mice expressing IkB in the T-cell lineage (Boothby et al., 1997; Esslinger et al., 1997) . In contrast, others reported a proapoptotic role for NF-kB in double-positive CD4 þ CD8 þ thymocytes (Hettmann et al., 1999; Kim et al., 2002a) . T-cell-specific expression of a CD2-IkBaM transgene conferred resistance to anti-CD3-mediated apoptosis (Hettmann et al., 1999) . Further studies will help to determine how NF-kB elicits different apoptotic responses in different contexts.
A possible role for NF-kB in suppressing apoptosis in the innate immune response A link between NF-kB and apoptosis has also surfaced in the innate immune response, which plays a fundamental role in the detection and elimination of pathogens. The nucleotidebinding oligomerization domain (NOD) proteins act as cytosolic regulators of inflammation and apoptosis ( Figure 1B ; reviewed in . NOD1 and NOD2 activate the canonical NF-kB pathway in a RICK-dependent manner (Bertin et al., 1999; Geddes et al., 2001; Ogura et al., 2001; Kobayashi et al., 2002) . NOD1 and IPAF activate caspase-1 to form an 'inflammasome' required for cleavage of IL-1b during the innate immune response (Poyet et al., 2001; Grenier et al., 2002; Martinon et al., 2002; Wang et al., 2002a; Yoo et al., 2002) . In addition to promoting expression of proinflammatory cytokines, NOD-mediated activation of NF-kB was shown in one instance to also promote transcription of antiapoptotic genes, as demonstrated by activation of the prosurvival Bcl-2 family member Bfl-1/ A1 following activation of NOD2 by bacterial muramyl dipeptide (MDP) . Interestingly NOD1, NOD2, IPAF and DEFCAP can also induce cell death in overexpression studies. In light of the dual capacity of some NOD proteins to both promote apoptosis and activate NF-kB, it is speculated that in a physiological context NF-kB-dependent activation of antiapoptotic genes by NOD2 might serve to modulate its proapoptotic effect . Further experimentation will test this hypothesis.
Toll-like receptors (TLRs) recognize extracellular microbial components in myelomonocytic cells and activate the NF-kB signaling pathway via IL-1-receptor-associated kinase (IRAK) and tumor necrosis factor (TNF) receptor-associated factor TRAF6 to induce production of proinflammatory cytokines and costimulatory molecules and trigger a defensive reaction ( Figure 1B ; reviewed in Takeda and Akira, 2001) . TLR activation has also been reported to trigger apoptosis in some cases e.g. (Aliprantis et al., 2000) . A recent example comes from the 19-kDa Mycobacterium tuberculosis protein (p19) that increased the rate of apoptosis of infected macrophages in a caspase-8-dependent manner (Lopez et al., 2003) . However, it is unclear whether NF-kB induces expression of antiapoptotic genes in this context. A recent report indicated that TLR4 activation increases neutrophil survival in an NF-kB-and mitogen-activated protein kinase (MAPK)-dependent manner via production of survival cytokines (Sabroe et al., 2003) . Thus it appears that similar to the NOD pathway, a picture is emerging in which both NFkB and apoptosis can be triggered upon TLR activation in some instances. Prolonged cell survival in these cases depends on the proper balance between proapoptotic and prosurvival signals induced in NF-kB-dependent or -independent manners.
A critical role for NF-kB in suppressing hepatocyte apoptosis NF-kB was ascribed both beneficial and damaging effects in the liver, owing to its role in liver development, regeneration and carcinogenesis (reviewed in Taub, 1998) . Several years ago, the dramatic phenotype of RelA-deficient mice provided compelling evidence to support a protective role for NF-kB in suppressing liver apoptosis. RelA þ animals succumb by days 15.5-16.5 of embryogenesis due to massive apoptosis of hepatocytes (Beg and Baltimore, 1996; reviewed in Li and Verma, 2002) . Mouse embryos lacking both RelA and NF-kB1 (i.e. the classical p50/p65 NF-kB dimer) died earlier, at about E13 of gestation (Horwitz et al., 1997) . The combined inactivation of RelA and c-Rel in compound knockouts also led to advanced death compared to RelA þ embryos, suggesting that the lack of RelA can be alleviated to some extent by c-Rel (Grossmann et al., 1999; Grossmann et al., 2000) . Not surprisingly, the recent analysis of animals deficient for upstream components of the NF-kB signaling cascade revealed a similar phenotype. Mice lacking IKKb, IKKg/NEMO or both IKKa/IKKb showed embryonic lethality between E12.5-E14.5 (Li et al., 1999a (Li et al., , c, 2000 Tanaka et al., 1999; Rudolph et al., 2000) . Homozygous deletion of the IKK kinase homologue T2K (TBK1, NAK), which associates with TRAF2 but is not a component of the IKK complex, also led to severe liver degeneration . The massive hepatocyte apoptosis in RelA and IKKb knockout animals was attributed to increased sensitivity to circulating TNFa, as embryonic liver apoptosis was not observed in compound knockouts for RelA and TNFa, or IKKb and TNF-R1 (Doi et al., 1999; Alcamo et al., 2001) . This agrees with the increased sensitivity of mouse embryonic fibroblasts (MEFs) and macrophages from relA þ mice to TNFainduced apoptosis (Beg and Baltimore, 1996) . It is interesting however that MEFs from T2K À/À mice are not sensitized to TNFa nor is NF-kB DNA-binding activity affected, although NF-kB's transcriptional activity is impaired in these cells . These recent findings suggest a role for T2K in suppressing embryonic liver apoptosis that apparently does not depend on degradation of IkB or NF-kB DNA binding. Studies in hepatocytes treated with transforming growth factor-b (TGF-b) further support a protective role for NF-kB. Prior studies indicated that TGF-b induces apoptosis by stabilizing IkBa and inactivating NF-kB (Arsura et al., 1997) . Recent work has shed further light on the subject by showing that TGF-b1 inhibits the ability of CK2 to stabilize IkBa in immortalized hepatocytes . Transient activation of NF-kB via a TAK1/IKK pathway was also described to play a role in increasing IkBa synthesis to repress NF-kB in liver epithelial cells, allowing TGF-b1-induced cell death to proceed through AP-1/SMAD ).
An essential role for NF-kB in the development and survival of hair follicles and epidermal appendages An important role for NF-kB in epidermal homeostasis and the development of skin appendages has only recently come to light. Five independent lines of investigation support this conclusion: (1) Mice that ubiquitously express a super-repressor of NF-kB (IkBDN) display impaired development of hair follicles and exocrine glands due to increased apoptosis (Schmidt-Ullrich et al., 2001 ). This phenotype is reminiscent of the human epidermal disorder hypohidrotic (anhydrotic) ectodermal dysplasia (HED), and is indistinguishable from that of mice with mutations in the genes encoding the TNF-related ligand ectodermal dysplasia (EDA) (tabby), its TNFR-related receptor ectodysplasin receptor (EDAR) (Downless) and crinkled (Cr or Edaradd for EDAR-associated death domain (DD)), a novel DD-containing adaptor that binds EDAR and mediates engagement of the NF-kB pathway (Headon et al., 2001; Yan et al., 2002) . (2) Heterozygous IKKg/NEMO females survive to birth but show traits reminiscent of those associated with human incontinentia pigmenti (IP), the first genetic disorder attributed to NF-kB dysfunction (SchmidtSupprian et al., 2000; reviewed in Smahi et al., 2002) . Mice heterozygous for IKKg have skin lesions with granulocyte infiltration, keratinocyte apoptosis and abnormal development of teeth, eyes and hair. TNFa plays an essential role in the development of IP lesions as human IP cells are highly sensitive to TNF-induced apoptosis and fail to elicit an NF-kB response. Patients with EDA also show abnormal development of ectoderm-derived structures (teeth, hair, nails, sweat glands) and display hypomorphic NEMO mutations (reviewed in Smahi et al., 2002) . (3) Conditional deletion of IKKb in the epidermis and hair follicles recapitulates many of the traits seen in IKKg/NEMO þ /À embryos, with the notable exception that the extensive keratinocyte apoptosis seen in NEMO knockouts was not observed in the skin of IKKb-deficient embryos (Pasparakis et al., 2002a) . The mutant phenotype caused by conditional inactivation of IKKb in the epidermis was suppressed in a TNFR-deficient background. (4) TRAF6-deficient mice suffer from HED due to impaired development of epidermal appendages (Naito et al., 2002) . Although TRAF6 does not associate with EDAR, it associates with X-linked ectodysplasin-A2 receptor (XEDAR) expressed in epidermal appendages and is essential for XEDAR-mediated NF-kB activation. (5) Loss of tumor suppressor CYLD causes the autosomal dominant syndrome cylindromatosis (turban tumor syndrome), that predisposes patients to benign tumors of hair follicles and cells of the sweat and scent glands (reviewed in Wilkinson, 2003) . Interestingly, CYLD was recently shown to interact directly with TRAF2 and IKKg/NEMO and to function as a TRAF2 deubiquitinating enzyme to negatively regulate IKKmediated activation of NF-kB downstream of CD40, XEDAR and EDAR (Brummelkamp et al., 2003; Kovalenko et al., 2003; Trompouki et al., 2003) . Loss of CYLD activates TNFa signaling through NF-kB and decreases apoptosis, whereas agents that antagonize NF-kB signaling interfere with cell death inhibition caused by loss of CYLD (Brummelkamp et al., 2003) . Altogether, the studies in this section highlight a critical role for NF-kB in suppressing apoptosis to allow differentiation and survival of hair follicles and epidermal appendages.
A double-edged sword: anti-and proapoptotic effects of NF-kB in the nervous system Functional NF-kB complexes (mostly p50 and p65) are present in essentially all cell types of the nervous system, including neurons, astrocytes, microglia and oligodendrocytes. Among the many stimuli that can activate NFkB in this system are membrane depolarization, nerve growth factor (NGF), opioids, the secreted form of bamyloid protein, TNF and glutamate (reviewed in Mattson and Camandola, 2001 ). However, the role of NF-kB within the developing and mature central nervous system has been controversial. While some studies report a proapoptotic role, most indicate a cytoprotective effect.
Accumulating evidence points to NF-kB as a survival determinant for neurons. Consistent with its expression pattern during development of the nervous system, NFkB was implicated in NGF-mediated protection of developing sensory neurons to cytokines (Hamanoue et al., 1999; Middleton et al., 2000) . Moreover, inhibition of NF-kB in primary rat cortical neurons with a super-repressor form of IkBa, a dominantnegative form of NIK, or NF-kB inhibitors parthenolide, SN50 or BAY 11-7082 triggers rapid activation of an intrinsic apoptotic program and is accompanied by reduced levels of NF-kB-regulated transcripts for antiapoptotic genes Bcl-2, Bcl-xL and Bfl-1/A1, in particular (Bhakar et al., 2002; Chiarugi, 2002) . Similarly, cultured relA 1999). Incidentally, despite the fact that homozygous inactivation of bcl-2 or bcl-x is embryonic lethal, embryos show severe loss of neurons in the central and peripheral nervous systems, suggesting a protective role for these NF-kB targets in developing neurons (Motoyama et al., 1995; Michaelidis et al., 1996) . In the PC12 model cell system, NGF stimulation was shown to activate NF-kB via the p75(NTR) and TrkA receptors and to result in different physiological effects (Foehr et al., 2000b) . Whereas NF-kB activation via the p75(NTR) receptor significantly blocked apoptosis, its activation via TrkA induced neurite process formation. Similarly, overexpression of NIK induced PC12 cell differentiation and antagonized cell death via the IKK and MAPK signaling cascades (Foehr et al., 2000a) . Consistent with these findings in cultured cells, embryos from IKKa/IKKb double knockout mice show defects in neurulation due to increased apoptosis. These were not apparent in the single knockouts, and it should be noted that embryos from IKKg/NEMO À/À mice lack neuronal defects . It was proposed that IKKa and IKKb have redundant effects during neuronal development and that NF-kB-independent mechanisms might be involved in the neuronal phenotype of the IKKa/IKKb double knockout, akin to the NF-kB-independent effects observed on the skin phenotype of IKKa À/À mice Li et al., 1999b; Takeda et al., 1999) .
Several experiments indicate that NF-kB is also neuroprotective in response to injury and that NF-kB decoys abolish protection (reviewed in Mattson and Camandola, 2001 ). NF-kB was shown to antagonize neurodegeneration in this context by triggering expression of various antiapoptotic genes including inhibitor of apoptosis proteins (IAPs) that protect neurons in experimental models of stroke or seizure, manganese superoxide dismutase (MnSOD) a mitochondrial antioxidant enzyme that is neuroprotective, and cell death inhibitors Bcl-2 and Bcl-xL (Mattson and Camandola, 2001 ). NF-kB was also ascribed a cytoprotective effect when induced by amyloid deposits in vivo and in cell culture studies of neurons (reviewed in Mattson and Camandola, 2001) . Indeed, exposure of cortical neurons to the amyloid beta-peptide associated with Alzheimer's disease leads to neurodegeneration and is accompanied by increased levels of IkBa and decreased NF-kB activity (Bales et al., 1998) . In contrast, the neuroprotective alpha-secretase-derived form of the beta-amyloid precursor protein activates NF-kB and protects against apoptosis induced by the neurotoxic amyloid betapeptide (Guo et al., 1998) . Increased NF-kB activity was also observed in other neurodegenerative disorders, such as Parkinson's disease and amyotrophic lateral sclerosis, whereby it may correspond to an early defense mechanism against oxidative stress and mitochondrial dysfunction (reviewed in Mattson and Camandola, 2001) . Consistent with this notion, p50-deficient animals treated with a mitochondrial toxin in an experimental model of Huntington's disease showed increased striatal neuronal damage and failure to upregulate MnSOD, in contrast to wild-type mice (Yu et al., 2000) . Contrary to the work described above, other reports described a proapoptotic effect for NF-kB in in vitro and in vivo models of neuronal cell injury (reviewed in Barkett and Gilmore, 1999; Denk et al., 2000) . Many of them converge on tumor suppressor p53, which was implicated as a detrimental factor for neuronal viability in response to ischemia/reperfusion and excitotoxic insult (Crumrine et al., 1994; Morrison et al., 1996; Xiang et al., 1996) . For instance, activation of the NMDA receptor by the excitotoxin quinolic acid triggers NF-kB activation and a concomitant increase of p53 and c-Myc expression in rat striatum, whereas its suppression prevented cell death (Qin et al., 1999) . A more recent study involving stimulation of rat striatal neurons with the glutamate receptor agonist kainic acid produced similar results (Nakai et al., 2000) . Since NFkB was described as a positive regulator of both p53 and c-Myc expression (Duyao et al., 1990; La Rosa et al., 1994; Wu and Lozano, 1994) , activation of NF-kB in these excitotoxic models of Huntington's disease was proposed to induce expression of c-Myc and p53 to trigger cell death.
Recently, individual NF-kB subunits were suggested to have opposing roles in modulating neuronal survival following exposure to the neurotoxin glutamate. Whereas glutamate activated p50/NF-kB1 and p65/ RelA in cultured rat cerebellar granule cells and mouse hippocampal slices, treatment with IL-1b that promotes neuron survival activated expression of c-Rel along with p50/NF-kB1 and p65/RelA (Pizzi et al., 2002) . NF-kB inhibition with antisense oligonucleotides implicated RelA in glutamate-mediated cell death, while c-Rel was essential for IL-1b-mediated survival in cerebellar granule cells. These results imply that the particular composition of NF-kB complexes may be a key factor in establishing neuronal cell survival or cell death. In this regard, a neuron-specific factor distinct from NF-kB was previously described to bind to kB DNA sites (neuronal kB binding factor, NkBF) (Moerman et al., 1999) . A recent follow-up on this work showed that NkBF consists of Sp1-related proteins and that its binding to kB DNA motifs can be competed by oligonucleotides containing an Sp1-binding motif (Mao et al., 2002) . Activation of ionotropic glutamate receptors reduced the activity of NkBF, consistent with the proteolytic degradation of Sp1-related factors in this context. It therefore appears that non-NF-kB-related factors may also play a role in determining neuronal cell fate. Future work will undoubtedly help to establish the contribution of this factor relative to that of bona fide NF-kB in the response of neurons to apoptotic signals.
Another important factor in the balance between the pro-and antiapoptotic effects of NF-kB in the nervous system appears to be the cell type. While many studies have proposed that NF-kB guards neurons from degeneration, its activation in microglia appears to foster neuronal cell death (reviewed in Mattson and Camandola, 2001) . Indeed, whereas homozygous inactivation of p50/NF-kB1 in mice significantly reduced ischemic neuronal death (Schneider et al., 1999) , NF-kB activation in microglia promoted ischemic neuronal degeneration most likely due to production of neurotoxic reactive oxygen species (ROS) and excitotoxins by activated microglia. Thus, while NF-kB may suppress the death of cells in which it is activated, its ability to induce expression of cytotoxic agents such as nitric oxide may promote the demise of other cells (reviewed in Mattson and Camandola, 2001) . Although the consequences of NF-kB activation in the nervous system remain somewhat controversial, it seems that some of the discrepancies might derive from the analysis of different cell types, experimental conditions, inducing signals and the particular NF-kB subunits involved (reviewed in Denk et al., 2000) . These issues deserve further investigation.
Implication of NF-kB in the cell response to viral infection
For many viruses, activation of NF-kB has been linked to their transforming activity. The first identified member of the Rel/NF-kB family, v-Rel, is in fact a viral protein derived from the cellular gene c-Rel. As the oncogene of the avian Rev-T retrovirus that causes fatal lymphoma in infected young birds, v-Rel suppresses apoptosis from a variety of death signals, and this appears to be important for its oncogenic effect (reviewed in Gilmore, 1999) . Indeed, cells that conditionally express v-Rel readily undergo apoptosis upon inactivation of the protein (White et al., 1995; Zong et al., 1997) . This is consistent with the resilience of tumor-derived cells transformed by v-Rel to proapoptotic stimuli (Neiman et al., 1991) . Recent work suggests that the oncogenic potential of Rel proteins arises at least in part from their ability to upregulate antiapoptotic proteins. Both v-Rel mutants with impaired transforming activity due to transactivation domain mutations or weakly transforming Rel proteins could be rescued by coexpression of death suppressors Bcl-xL or Bcl-2 (White and Gilmore, 1996; Gilmore et al., 2001; Rayet et al., 2003) . In support of this idea, v-Rel upregulates expression of c-IAP1 in transformed cells and does so at higher levels than its cellular homologue c-Rel (Kralova et al., 2002) .
The Tax oncoprotein of human T-cell leukemia virus type-1 (HTLV-1) immortalizes T cells in an NF-kBdependent manner and is implicated in adult T-cell leukemia (ATL). Suppression of NF-kB in Tax-induced mouse tumor cells sensitizes them to proapoptotic stimuli (Portis et al., 2001) . As seen in HTLV-1-immortalized T cells and those of ATL patients, Taxmediated activation of NF-kB induces death-suppressive genes, such as Bcl-xL, Bcl-2 and Bfl-1/A1 (Harhaj et al., 1999; Tsukahara et al., 1999; Nicot et al., 2000) . NF-kB is also linked to transformation by the oncogenic human herpesvirus Epstein-Barr Virus (EBV) that is implicated in Burkitt's lymphoma. Its latent membrane protein 1 (LMP1) suppresses apoptosis and is required for human B-cell transformation by EBV (CahirMcFarland et al., 2000; Feuillard et al., 2000; He et al., 2000; reviewed in Hiscott et al., 2001) . LMP1 was recently shown to upregulate expression of Bfl-1/A1 via a novel NF-kB-like binding site and this increase conferred protection against apoptosis induced by growth factor deprivation in an EBV-positive cell line exhibiting a latency type I infection (D'Souza et al., 2000 (D'Souza et al., , 2003 . Contrary to these findings and others, LMP1 was recently reported to induce cell death via NF-kB-dependent activation of caspase-3 (Nitta et al., 2003) . In this study, LMP1 failed to induce death in absence of RelA or upon inhibition of NF-kB. Although the reason for this discrepancy remains to be determined, the use of different cell types should be noted. The human herpesvirus 8 is linked to Kaposi's sarcoma and primary effusion lymphoma. Its v-FLIP protein suppresses apoptosis triggered by growth factor deprivation by persistently activating the IKK kinase complex thereby inducing expression of Bcl-xL (Liu et al., 2002; Sun et al., 2003) . Lastly, gammaherpesviruses establish latent infections in lymphocytes and are implicated in nasopharyngeal carcinoma, Kaposi's sarcoma and B-cell lymphomas. NF-kB was recently implicated in promoting latency in gammaherpesvirusinfected cells, as its overexpression in epithelial and fibroblast cells suppressed replication of murine herpesvirus 68 (MHV68) and blocked activation of lytic promoters from MHV68 and Kaposi's sarcoma-associated herpesvirus (KSHV) (Brown et al., 2003) . In contrast, NF-kB inhibition in KSHV-infected cells led to lytic protein synthesis and virus reactivation.
There are a number of other examples in which viruses utilize NF-kB to block apoptosis as a means to enhance their replication or their pathogenicity (reviewed in Hiscott et al., 2001; Santoro et al., 2003) . The effects of HIV-encoded proteins Tat, Vpr, Nef and envelope glycoprotein gp120 on the NF-kB pathway, and in turn those that NF-kB exerts on HIV replication and apoptosis are well documented and were reviewed extensively (reviewed in Barkett and Gilmore, 1999; Hiscott et al., 2001; Santoro et al., 2003) . The herpes simplex virus 1 envelope glycoprotein D and hepatitis C virus core protein induce NF-kB and confer resistance to apoptotic stimuli-like TNFa (Tai et al., 2000; Goodkin et al., 2003; Medici et al., 2003) . Encephalomyocarditis virus (EMCV) also abrogates apoptosis via NF-kB as a means to enhance its pathogenic effects. In fact, p50 À/À mice survive EMCV infections that would otherwise kill wild-type animals (Schwarz et al., 1998) . Interestingly, African swine fever virus (ASFV) encodes two proteins that have opposite effects on NF-kB activation (reviewed in Gilmore et al., 2003) . The early viral protein A238L acts like a degradationresistant mutant of IkB to blunt the initial burst of NF-kB activity that follows infection and suppress host immune and inflammatory responses. On the other hand, the IAP-like ASFV protein A224L is expressed later during the course of infection and activates NF-kB via the IKK kinase complex to seemingly suppress apoptotic caspases and lengthen the infection (Rodriguez et al., 2002) .
On the flip side, certain viruses exploit the NF-kB cascade to induce cell death. Precedents include Dengue, Sindbis and Reovirus that promote apoptosis in infected cells, whereas death was inhibited by NF-kB decoys or in cells lacking p50 or p65 (Lin et al., 1995; Marianneau et al., 1997; Connolly et al., 2000; Jan et al., 2000) . However, the generality of NF-kB's proapoptotic effects in the pathogenicity of flaviviruses was recently brought into question, as contrary to Dengue, Taiwanese Japanese Encephalitis virus could replicate and trigger apoptosis in cells in which NF-kB activity was stably suppressed (Liao et al., 2001) .
Lastly, other viral proteins such as human adenovirus E1A suppress NF-kB to sensitize cells to proapoptotic stimuli (Shao et al., 1997 (Shao et al., , 1999 . E1A blocks the activity of the IKK complex, and was recently shown to antagonize expression of the NF-kB-regulated antiapoptotic protein c-FLIP(s) that inhibits caspase-8 activation during TNFa signaling (Shao et al., 1999; Perez and White, 2003) . Overall, although distinct viruses interface differently with the NF-kB signaling cascade, it is clear that many of them have evolved means to influence this important pathway to advantage the host or the virus during infection.
NF-kB weighs in the balance to regulate life and death decisions in death receptor (DR) pathways: new insights
TNFa is a key cytokine that regulates immune responses, cell differentiation and apoptosis. Activation of TNF receptors TNFR1 or TNFR2 by TNFa represents the quintessential pathway balancing the induction of cell death with its inhibition through activation of NF-kB. Although many players involved in the TNFR signaling cascade have been identified, the mechanism(s) that determine whether the death or survival branch of the pathway will prevail has not been entirely clarified. A recent study by Micheau and Tschopp (2003) sheds new light on the issue. Their study demonstrates that two separate complexes can form following trimerization of TNFR1 in response to TNFa and recruitment of TRADD and RIP1 (Figure 2) . Complex I binds TRAF2, leading to NF-kB activation and consequent transcriptional activation of caspase-8 inhibitor FLIP (CASPER). Complex II arises when TNFR1, TRADD and RIP1 are modified, possibly via mono-and/or diubiquitination, and contrary to expectation, the complex dissociates from TNFR1. When released freely into the cytoplasm, complex II recruits FADD, likely through an interaction between the TRADD and FADD DDs. Caspase-8 and either the proapoptotic caspase-10 (for death) or the caspase regulator c-FLIP(L) (for survival) are then recruited in a mutually exclusive interaction. The onset of apoptosis depends upon how effectively complex I induces c-FLIP(L) synthesis to suppress death signaling by complex II. These new findings imply that the deathregulating complex forms in the cytosol, consistent with prior work that failed to demonstrate a direct physical association of FADD and caspase-8 with TNFR1 (Harper et al., 2003) . The results also agree with earlier studies with c-FLIP (CASPER) knockout mice, whereby elimination of FLIP highly sensitized cells to TNFa-and FasL-induced apoptosis .
Figure 2 TNF-R1 activation upon binding of cytokine TNFa leads to the formation of two sequential complexes. Complex I is comprised of TRADD, RIP1 and TRAF2, and is responsible for activating NF-kB signaling, which upregulates antiapoptotic genes. Following modification (possibly mono-or diubiquitination) and endocytosis, the protein complex recruits FADD, procaspase-8 and -10, producing complex II, which initiates an apoptotic signal pathway. The fate of the cell is determined by the balance between NFkB-dependent antiapoptotic genes and proapoptotic factors that act in the death cascade, through interactions that can occur at different steps along the death pathway. Binding of FLIP competes with procaspase-10 in complex II, while the antiapoptotic Bcl-2 family members Bfl-1/A1, Bcl-xL, NR13 and Bcl-2 block the release of cytochrome c from mitochondria. IAPs, including XIAP, c-IAP1 and c-IAP2, can bind and silence effector caspases. A complete list of antiapoptotic NF-kB target genes is found in Table 1 Rel/NF-jB and apoptosis J Kucharczak et al Other factors were found to also weigh in the balance to favor the life-or death-promoting branches of this pathway. These include caspase-3-mediated proteolysis of IKKb to suppress NF-kB activation during TNFainduced apoptosis (Tang et al., 2001b) . Another mechanism by which NF-kB can protect cells against TNFa-induced demise involves inhibition of lysosomemediated apoptosis (Liu et al., 2003) . Cell treatment with TNFa triggers the lysosomal release of cathepsin B, shown in recent years to play an important role in mitochondria-independent cell death via caspase-dependent and -independent pathways. The inhibitory effect of NF-kB in this context is mediated by upregulation of the serine protease inhibitor Spi2A, a potent inhibitor of cathepsin B (Liu et al., 2003) . NF-kB has also been found to help scavenge oxygen radicals induced by TNFa by upregulating new enzymes involved in ROS metabolism (G Franzoso, personal communication).
Distinct effects for distinct subunits Parenthetically, it seems that not all NF-kB subunits have the same capacity to suppress apoptosis induced by DRs. Whereas RelA is required to protect cells from TNFa, some groups reported that c-Rel is dispensable for viability in response to TNFR-and Fas-mediated apoptosis. Indeed, c-Rel À/À fibroblasts are refractory to TNF-mediated cell death, as are c-Rel À/À B cells from Fas-mediated apoptosis (Owyang et al., 2001; Chen et al., 2003) . In contrast, c-Rel is well recognized to be necessary for protecting B cells from antigen receptormediated cell death (Wu et al., 1996b; Grumont et al., 1998; Owyang et al., 2001) . Subunit-specific regulation was also suggested in the Apo2L/TRAIL signaling pathway, although the protective activity of NF-kB in this context has been the subject of controversy. One report showed that T-cell death induced by HTLV-1 Tax is dependent on NF-kB signaling and involves activated expression of DR ligand TRAIL (RiveraWalsh et al., 2001) . In contrast, inhibition of NF-kB in breast cancer cells induced expression of DR5 (TRAIL-R2) and adaptor protein TRADD, sensitizing cells to TRAIL-induced apoptosis . Overexpression of RelA could protect MEFs from TRAILinduced apoptosis by inhibiting expression of caspase-8, DR4 (TRAIL-R1) and DR5 (TRAIL-R2), and enhancing expression of inhibitors of apoptosis c-IAP1 and c-IAP2 to decrease simultaneously formation of DR complexes and inhibit active pathways. Conversely when c-Rel was expressed under the same conditions, DR4, DR5 and the proapoptotic Bcl-xS protein were upregulated, concomitant with inhibition of c-IAP1, c-IAP2 and survivin. However, these effects may be cell specific as c-Rel expression in HeLa cells increased resistance to TRAIL by upregulating the decoy receptor protein DcR1 (Bernard et al., 2001b) . In another study, RelA-mediated induction of Bcl-xL was implicated in suppressing TRAIL-mediated apoptosis (Ravi et al., 2001) , although others do not support an important role for Bcl-xL in this pathway (Walczak et al., 2000) . Since many of these studies evaluated the effects of NF-kB subunits using protein overexpression and in different cell systems, future analyses looking at their activity under more physiological conditions will certainly help to clarify their effects.
Crosstalk between NF-kB and JNK: something to live for
In addition to turning on NF-kB signaling, TNF induces the stress-activated Jun kinase (JNK), a member of the MAPK family. Although JNK can cause cell death by activating the mitochondrial apoptotic pathway, it can also promote cell survival depending on the cell context. The existence of negative crosstalk between the NF-kB and JNK pathways has recently come to light and was implicated to be responsible for the transient activation of JNK in response to TNFa ( MEFs showed that NF-kB suppresses JNK activity by upregulating expression of the caspase inhibitor Xchromosome-linked inhibitor of apoptosis (XIAP), although others noted that the protective activity of XIAP depends upon JNK1 activation (Sanna et al., 2002) . Other studies found that GADD45b/MyD118, an NF-kB target gene that belongs to the GADD45 family of factors involved in cell cycle control and DNA repair, is involved in suppressing JNK signaling at the level of JNKK2/MKK7 (De Smaele et al., 2001; Papa et al., 2003) . The NF-kB-regulated zinc-finger protein A20, which antagonizes TNF induction of JNK, is another possible contender (Lademann et al., 2001) . Nevertheless, elimination of XIAP in MEFs was not sufficient to abolish inactivation of JNK by NF-kB (A Lin, personal communication). Similarly, Amanullah et al. (2003) commented that mice deficient for gadd45b apparently show no defect in TNFa signaling or cell survival. Some differences in experimental conditions have been noted between this study and that of De Smaele et al., but it remains to be determined whether these might explain these discrepancies (Zazzeroni et al., 2003b) . Recent work by Sakon et al. (2003) proposed that NF-kB prevents sustained JNK activity in TNF-treated cells by inhibiting accumulation of reactive oxygen species. Based on these analyses, it appears that a combination of these or other NF-kBregulated genes might be necessary to suppress JNK activity in response to TNF. There is a consensus that further analyses will be needed to clarify the contribution of these and other NF-kB-regulated factors to the control of JNK signaling. It is undisputed that suppression of NF-kB activity leads to prolonged activation of JNK, yet the outcome of this activation on the fate of the cell remains somewhat controversial. Several analyses found that in the absence of NF-kB, persistent JNK activity is proapoptotic (De Smaele et al., 2001; Javelaud and Besancon, 2001; Tang et al., 2001a; Lamb et al., 2003) . In contrast Reuther-Madrid et al. (2002) showed that persistent activation of JNK is antiapoptotic in TNFatreated NF-kB-null cells, and that inhibitors of JNK enhanced TNF-induced killing in this context. Thus, opposite results were obtained in studies that both used the same RelA À/À MEFs activated by TNF and treated with JNK inhibitor SP600125, although there were some differences in the dose and duration of the TNFa treatment (Tang et al., 2001a; Reuther-Madrid et al., 2002) . It should perhaps be noted that not 100% of the cells died upon suppression of persistently activated JNK in TNF-treated RelA À/À MEFs in the former study, and that cell death protection was not 100% effective following JNK inhibition in the latter.
Recent work in JNK À/À fibroblasts indicates that JNK induces expression of transcription factor JunD and that NF-kB collaborates with this JNK/JunD pathway in wild-type cells to enhance expression of c-IAP2, a caspase inhibitor that also interacts with TRAF2 and inhibits TNF-induced apoptosis (Lamb et al., 2003) . These findings imply that NF-kB-mediated cell survival in cells treated with TNF requires the transient activation of JNK, and that when NF-kB is absent JNK activation is persistent and apoptosis ensues (Lamb et al., 2003) . Clearly, the interplay between the JNK and NF-kB signaling pathways is important but nonetheless complex. It is a topic of intense investigation that will undoubtedly continue to shed new light on the regulation of cell fate.
Answering the suicide hotline: how NF-kB regulates programmed cell death As illustrated above, the relationship between NF-kB and apoptosis is intricate. To complicate things further, while NF-kB generally exploits its transcriptional activity to regulate the expression of genes that function in death signaling, there are an increasing number of reports that indicate other modes of action. This section reviews recent developments in this arena.
Mechanisms for NF-kB-mediated protection from apoptosis
Transcriptional activation of antiapoptotic genes As summarized in Table 1 , NF-kB activates the transcription of many genes capable of suppressing cell death (reviewed in Barkett and Gilmore, 1999; Karin and Lin, 2002; Burstein and Duckett, 2003) . By and large, this is the most common way for NF-kB to antagonize apoptosis. Genes in this category contain functional NF-kB-binding sites in their regulatory region, undergo NF-kB-mediated activation in response to death-inducing stimuli, and can suppress apoptosis under conditions where NF-kB is inactivated, although several show partial activity in this context. This most likely reflects the need for cooperative action to antagonize different apoptotic challenges in different cells efficiently. Among them are prosurvival members of the mammalian Bcl-2 gene family Bcl-xL, NR13 and Bfl-1/A1 (Grumont et al., 1999; Lee et al., 1999a, b; Wang et al., 1999b; Zong et al., 1999; Chen et al., 2000) . Bcl-2 itself recently joined this group, owing to its NF-kB-dependent induction that conferred protection against hypoxia-and nitric oxideinduced injury in primary hippocampal neurons and its ability to promote the survival of peripheral B cells in response to c-Rel and RelA (Tamatani et al., 1999; Grossmann et al., 2000) . Factors in this group suppress the release of proapoptotic cytochrome c and Smac/ Diablo from mitochondria and can block programmed cell death in response to varied stimuli including TNFa, antigen receptor ligation and chemotherapeutic agents like etoposide (Grumont et al., 1999; Lee et al., 1999a; Wang et al., 1999b; Zong et al., 1999; Reed and Green, 2002; Sun et al., 2002) .
Other antiapoptotic NF-kB target genes include XIAP that inhibits the processing of procaspase-9 and the activities of caspase-7 and -3, and was implicated in NF-kB-mediated suppression of JNK signaling (Stehlik et al., 1998; Tang et al., 2001a) . The cellular inhibitors of apoptosis c-IAP1, c-IAP2 and the TNF receptorassociated factors TRAF1 and TRAF2, are also activated in response to NF-kB and were implicated to act jointly with one another to suppress TNF-induced cell demise in RelA À/À MEFs, although coexpression of c-IAP1 and c-IAP2 alone was adequate to confer resistance to etoposide-induced death (Chu et al., 1997; You et al., 1997; Deveraux et al., 1998; Stehlik et al., 1998; Schwenzer et al., 1999; Chen et al., 2003) . The zinc-finger protein A20 was described several years ago as a dual inhibitor of NF-kB activation and TNF-provoked death (reviewed in Beyaert et al., 2000) . Recent work uncovered a role for A20 in controlling the balance between the Fas and TNF death pathways during AICD in T cells (Malewicz et al., 2003) . c-FLIP is a potent negative regulator of DR-induced apoptosis (Kreuz et al., 2001; Micheau et al., 2001) . Gadd45b is a new recruit to the antiapoptotic NF-kB-regulated targets. It was implicated in NF-kB-mediated suppression of JNK in response to TNF, and in mediating the cytoprotective activity of CD40 against Fas-induced death in B cells (De Smaele et al., 2001; Zazzeroni et al., 2003a) . MnSOD also belongs to this category, as an NF-kBinduced enzyme that scavenges cytotoxic ROS generated by various apoptotic pathways (Bernard et al., 2001a (Bernard et al., , 2002 Delhalle et al., 2002; Tanaka et al., 2002) . Lastly, there have been new developments regarding the controversial role of the immediate-early response gene iex-1 in NF-kB-mediated survival. A variant of IEX-1 (IEX-1L) was previously reported to mediate cytoprotection by NF-kB (Wu et al., 1998) , but its role in suppressing apoptosis has been the subject of controversy (Schafer et al., 1999; Arlt et al., 2001; Schilling et al., 2001; B Rayet and C Ge´linas, unpublished data) . Of late, Wu (2003) published that whereas IEX-1 sensitizes some cells to apoptosis when overexpressed in vitro, its constitutive expression in the lymphocytes of IEX-1 transgenic mice prevents activated T cells from undergoing stimuli-induced apoptosis. In this in vivo context, IEX-1 gave rise to a lupus-like condition and the mice developed T-cell lymphomas. These provocative new findings deserve further investigation.
Alternative means to enhance cell survival A few reports have suggested alternative means for NF-kB to enhance cell viability. Three recent examples come to mind. The first comes from studies of p53-mediated cell death in IKKa À/À IKKb À/À double knockout MEFs, in which IKKb-mediated activation of NF-kB led to increased levels of Mdm2, destabilization of p53 and resistance to doxorubicin-induced apoptosis (Tergaonkar et al., 2002) . The second is the suppression of caspase-8, DR4 (TRAIL-R1) and DR5 (TRAIL-R2) gene expression by RelA in cells stimulated with the death-inducing ligand TRAIL . This came along with enhanced expression of c-IAP1 and c-IAP2. The third example is one in which expression of the proapoptotic Bcl-2 family member Bax was increased following expression of a dominant inhibitor of NF-kB in cancer cell lines (Bentires-Alj et al., 2001) . Although a functional NF-kB-binding site was identified in the Bax promoter region, this site was dispensable for NFkB-mediated suppression of Bax promoter activation by p53. Nevertheless, it is conceivable that suppression of Bax activation by NF-kB might contribute to the survival of some tumor cells, although the mechanism for this repression needs to be clarified. Finally, NF-kB and IkB subunits have been observed to localize to mitochondria, and to suppress mitochondrial gene expression (Bottero et al., 2001; Cogswell et al., 2003) . Bottero et al. (2001) showed an interaction between mitochondrial IkB and the ANT adenine nucleotide transporter, which regulates the mitochondrial permeability transition. In light of the critical role of this organelle in the execution and amplification of many apoptotic programs, these intriguing new findings give rise to speculation that NF-kB-dependent mechanisms operating at the level of mitochondria may perhaps contribute to its protective activity. However, further investigation is needed to ascertain this.
Mechanisms through which NF-kB promotes cell death
Despite a large body of evidence supporting the antiapoptotic role of NF-kB, there are a growing number of scenarios in which NF-kB behaved in a proapoptotic fashion. One such study published a few years ago concluded that tumor suppressor p53 activates NF-kB via MEK1 and pp90 rsk , and that NF-kB plays a vital role in p53-mediated apoptosis (Ryan et al., 2000) . Inhibition of MEK1 or absence of RelA abrogated p53-induced cell death. However, overexpression of RelA in a p53-deficient background failed to induce apoptosis, suggesting that RelA might be necessary but not sufficient for the proapoptotic phenotype of p53.
A recently published pair of papers from the group of N Perkins offers an interesting counterpoint to this theory. In the first, Rocha et al. (2003a) demonstrate that the tumor suppressor ARF, which normally activates p53 by inhibiting Mdm2, can also inhibit the transcriptional activity of NF-kB in cells stimulated with TNFa or the chemotherapeutic agent etoposide (N Perkins, personal communication) . This inhibitory effect is independent of p53 and Mdm2, and serves to downregulate expression of antiapoptotic proteins controlled by NF-kB, such as Bcl-xL. The study shows that ARF induces association of the RelA transactivation domain with histone deacetylase 1 (HDAC1) to repress NF-kB's transcriptional activity in a promoter-specific manner. The second paper addresses the effect of p53 on NF-kB-mediated transcription and cell cycle regulation (Rocha et al., 2003b) . Cyclin D1, involved in the G1-S phase transition, is transcriptionally regulated by NFkB primarily through a Bcl-3/p52 complex . Rocha et al. (2003b) show that p53 suppresses expression of Bcl-3, an IkB-related protein that acts as a transcriptional coactivator with p52. At the same time, p53 promotes association of p52 with HDAC1 to repress cyclin D1 transcription. Since ARF is able to regulate p53, these findings create a scenario in which ARF negatively regulates the antiapoptotic and proproliferative activities of NF-kB, thereby creating a situation where NF-kB is no longer able to inhibit cell death without necessarily promoting it either. When extrapolated to the findings of Ryan et al., these exciting new results lead one to speculate that perhaps p53 does not activate a proapoptotic activity of NF-kB, but rather neutralizes its capacity to stimulate expression of antiapoptotic genes that would otherwise counteract p53-dependent apoptosis. In this scenario, ARF and p53 might be thought of as guardians of the antiapoptotic and proproliferative activities of NF-kB. It will be intriguing to see if future experiments confirm these predictions.
There exist several other studies in which NF-kB sensitized cells to death-inducing signals (for example, Jung et al., 1995; Grimm et al., 1996; Lin et al., 1998; Hettmann et al., 1999) . In some of these cases, NF-kB induced expression of death-promoting genes (Table 1) . These include tumor suppressor p53, the DR Fas and its ligand FasL and TNFa Shakhov et al., 1990; Wu and Lozano, 1994; Kasibhatla et al., 1998 Kasibhatla et al., , 1999 Matsui et al., 1998; Chan et al., 1999; Zheng et al., 2001) . For instance, NF-kB induces FasL expression in T cells in response to AICD (Kasibhatla et al., 1999) . Recently, nitric oxide-induced activation of p38 was implicated in triggering NF-kB-mediated expression of p53, leading to upregulation of the proapoptotic Bcl-2 family member Bax, just as cyanide-induced activation of NF-kB resulted in activation of the proapoptotic Bcl-xS and Bax proteins (Kim et al., 2002b; Shou et al., 2002) . Other examples include NFkB-dependent activation of DR ligand TRAIL and TNF receptor family member DR6 (Baetu et al., 2001; Kasof et al., 2001; Rivera-Walsh et al., 2001; Siegmund et al., 2001) . In one study, c-Rel induced expression of TRAIL receptors DR4 (TRAIL-R1), DR5 (TRAIL-R2) and the proapoptotic Bcl-2 family member Bcl-xS to sensitize cells to TRAIL-induced apoptosis . Although the antiapoptotic bcl-xl transcript was previously shown to be transcriptionally regulated by NF-kB, this the first report of the proapoptotic product Bcl-xS being induced by NF-kB. Since Bcl-xL and BclxS are derived by alternative splicing, this raises the possibility that in some instances c-Rel is perhaps capable of influencing the splicing reaction to benefit production of one form over the other.
Activation of death-causing genes is not the only way in which NF-kB is involved in promoting apoptosis. While c-Rel upregulates expression of MnSOD to suppress cell death by converting toxic O À 2 to H 2 O 2 , over time the buildup of hydrogen peroxide itself triggers apoptosis (Bernard et al., 2002) . This underscores the idea that timing and environment can convert an antiapoptotic signal into a death signal. NF-kB can also work indirectly to upregulate the expression of other transcription factors that in turn activate genes that regulate cell death and/or proliferation. Examples include p53, IRF-1 that works along with NF-kB to stimulate production of the death-promoting inducible nitric oxide synthase after ischemic injury, and E2F3a that induces expression of cyclin E to promote cell cycle progression (Wu and Lozano, 1994; Cheng et al., 2003; reviewed in Denk et al., 2000) . Finally, one study last year claimed that the presence of a DD in p100/NF-kB2 allows it to promote apoptosis via recruitment to DRs and activation of apical caspase-8 (Wang et al., 2002b) . It was suggested that the loss of this proapoptotic effect might be necessary for the oncogenic activity of rearranged nf-kB2 genes observed in human lymphomas. However, others have expressed concerns regarding the physiological relevance of these findings in light of experimental conditions and of the phenotype of mice in which expression p100/NF-kB2 was inactivated (Hacker and Karin, 2002) . The involvement of p100/ NF-kB2 as an activator of cell death therefore remains contentious.
Factors that influence NF-kB's decision between life and death
There are several factors that influence the transcriptional activity and biological function of NF-kB and this in turn might affect its capacity to weigh in the balance between life and death. This section highlights those that were recently implicated in modulating its transcriptional activity, its relationship with factors that regulate death signaling, and its effect on cell cycle control.
Modulation of NF-kB's transcriptional activity
Post-translational modification has surfaced as an important means to modulate NF-kB's transcriptional activity. The IKK complex, casein kinase II and AKT are among the kinases that can phosphorylate the transactivation domains of RelA or c-Rel in response to NF-kB-inducing stimuli Sakurai et al., 1999; Martin and Fresno, 2000; Wang et al., 2000; Mayo et al., 2002; Sizemore et al., 2002; Yang et al., 2003) . On the other hand, the catalytic subunit of protein kinase A (PKAc), MSK1 and PKCz phosphorylate the RHD of RelA (Zhong et al., 1997; Duran et al., 2003; Vermeulen et al., 2003) . In the case of PKAc, this modification is necessary for RelA interaction with transcriptional coactivator p300 (Zhong et al., 1998 (Zhong et al., , 2002 . Another RelA-interacting factor, protein phosphatase 2A, was implicated in its dephosphorylation (Yang et al., 2001) . Acetylation of NF-kB subunits adds another level of regulation, as acetylation of RelA prevented its association with newly synthesized IkBa and interaction with corepressor HDACs (Ashburner et al., 2001; Chen et al., 2001) . The effects of these different modifications on the pro-and antiapoptotic activities of NF-kB remain to be explored. However, a RelA mutant that could no longer be phosphorylated by PKAc (S276A) failed to rescue TNF-induced apoptosis of RelA À/À MEFs, and a knockin of this mutation is lethal in mice S Ghosh, personal communication) . Moreover, Akt was shown to suppress cell death by stimulating the transactivation potential of RelA (Madrid et al., 2000) .
c-Rel and RelA functionally interact with diverse transcriptional coactivators. The TAFII105 component of TFIID was shown to mediate NF-kB-dependent transactivation of antiapoptotic genes like A20, whereas a dominant-negative TAFII105 mutant sensitized cells to TNF-induced killing (Yamit-Hezi and Dikstein, 1998; Yamit-Hezi et al., 2000) . Novel interactions between NF-kB and tumor suppressors ARF and BRCA1 have recently surfaced. ARF inhibited NF-kB-mediated transcription in a promoter-specific manner and downregulated expression of the antiapoptotic Bcl-xL protein (Rocha et al., 2003a) . Conversely, interaction of the RHD of RelA with BRCA1 enhanced NF-kB-mediated transcription of the proapoptotic gene Fas (Benezra et al., 2003) . Lastly, c-Rel was recently shown to act in concert with AP-1 and C/EBPb to recruit coactivators TAFII250 and p300 and upregulate Bfl-1 gene expression in activated T cells via an enhanceosome-like complex . In studies with null fibroblasts, c-Myc was revealed to sensitize cells to TNF-induced death by inhibiting p65-mediated transactivation of Bfl-1/A1 (You et al., 2002) .
Interplay between NF-kB and factors that regulate death signaling NF-kB participates in a number of other interactions with proteins involved in the apoptotic cascade, which affect its protective activity to either break or amplify the survival response.
Caspase-mediated cleavage of NF-kB and IkB: alternative means to promote cell death Cysteine proteases known as caspases are major effectors of apoptosis that are activated upstream or downstream of mitochondria and cleave substrates in a sequence-specific manner. Among their targets are structural proteins, nuclear lamins and a number of apoptosis regulators, such as Bcl-2 (Johnson and Boise, 1999). It is perhaps not surprising that in order to blunt the cell's survival response, NF-kB is a substrate for caspase cleavage. Caspase-3-mediated cleavage of RelA, p50 and c-Rel upon treatment with death-inducing ligands FasL or TNFa has come to light (Ravi et al., 1998; Barkett et al., 2001) . Caspase-mediated processing of IkB was portrayed as another means to suppress the protective activity of NF-kB and promote an apoptotic response. Independent studies showed that the N-terminus of IkBa undergoes caspase-3-mediated cleavage, coincident with apoptosis (White et al., 1995; White and Gilmore, 1996; Barkett et al., 1997; Jung et al., 1998; Reuther and Baldwin, 1999) . The product of this cleavage is an IkBa molecule that is resistant to signal-induced degradation by the proteasome, and that acts as a constitutive inhibitor of NF-kB to promote cell death . Lastly, the Drosophila caspase homologue Dredd interacts with the Drosophila NF-kB factor Relish to promote its endoproteolytic cleavage (Stoven et al., 2003) . This processing of Relish generates a RHD fragment capable of DNA binding and a stable fragment resembling IkB. In this particular case, this caspase action contributes a gain-of-function toward Relish and is independent of apoptosis.
A new role for FADD as a regulator of NF-kB signaling FADD is best known for its role as an adaptor that recruits caspase-8 to activated Fas receptors to signal downstream activation of cell death. However, there have been reports of late implicating FADD in the regulation of NF-kB signaling, although the outcome of this regulation is contentious. Initial reports showed that FADD and caspase-8 activate NFkB via IKK, independent of the proteolytic activity of caspase-8 but dependent on its death effector domaincontaining prodomain (Chaudhary et al., 2000; Hu et al., 2000; Schaub et al., 2000) . Contrary to this claim, recent work showed that FADD activates caspase-8 in response to TNF or TLR-4 signaling, but that it simultaneously suppresses NF-kB activation from TLR-4 possibly via interaction with adaptor protein MyD88 (Bannerman et al., 2002) . Consistent with this model, FADD À/À MEFs showed enhanced activation of NF-kB upon lipopolysaccharide (LPS) treatment. The discrepancies between these studies might be explained by differences in experimental conditions (transient vs stable expression), in cell type and/or stimulation (reviewed in Duckett, 2002) . Undoubtedly, further studies into this novel function of FADD will help to understand its effects on NF-kB and its implication in the control of the cell death response.
Bcl-2 feedsback to downregulate NF-kB activity Whereas NF-kB transactivates prosurvival members of the Bcl-2 family (Table 1) , there have been some reports in which Bcl-2 suppressed NF-kB activity by stabilizing IkBa, by blunting the transactivation potential of RelA or by influencing the nuclear accumulation of NF-kB subunits (Ivanov et al., 1995; Lin et al., 1995; Grimm et al., 1996; de Moissac et al., 1998; Badrichani et al., 1999) .
Positive feedback of IAPs to amplify NF-kB's protective activity IAPs were reported to increase NF-kB activity, and by the same token, enhance its antiapoptotic function. H-IAP1, a member of the IAP family, could promote IkBa degradation, thereby potentiating the ability of NF-kB to suppress TNFa-induced apoptosis (Chu et al., 1997) . These results imply that the IAPs, which are transcriptionally activated by NF-kB, may provide positive feedback to amplify its cytoprotective activity.
Effects of NF-kB on cell cycle control
Since aberrant proliferation signals are often conducive to cell suicide, it is relevant to review recent findings that pertain to the effects that NF-kB exerts on cell cycle control. Consistent with the implication of NF-kB in promoting cell proliferation, NF-kB was shown to regulate the expression of cyclins D1, D2, D3 and more recently cyclin E (Guttridge et al., 1999; Hinz et al., 1999 Hinz et al., , 2001 Hsia et al., 2002) . For example, B cells from c-rel
double-knockout mice show defective proliferative response to mitogenic stimulation that results in G1 phase arrest (Kontgen et al., 1995; Hsia et al., 2002; Pohl et al., 2002) . Hsia et al. (2002) linked the proliferative defect of c-rel À/À B cells to a failure to express cyclins D3 and E. Recently, the same group reported that c-Rel activates expression of transcription factor E2F3a that, in turn, is likely to transactivate cyclin E . Others showed that NF-kB-mediated transactivation of cyclin D1 is essential for the transforming activity of the oncoprotein v-Abl, and is increased in mammary carcinomas arising in MMTV-c-Rel transgenic mice (Nakamura et al., 2002; Romieu-Mourez et al., 2003) . In agreement with these findings tumor suppressor p53, which plays a central role in cell cycle control, was revealed to inhibit cyclin D1 expression by favoring formation of nonfunctional p52/HDAC1 complexes over transcriptionally active p52/Bcl-3 complexes (Rocha et al., 2003b) . Furthermore, RelA participates in protein-protein interactions with the cell cycle regulatory complex cyclin E-Cdk2 via its association with CBP/p300, and with the p16Ink4 cyclin-dependent kinase inhibitor (Perkins et al., 1997; Wolff and Naumann, 1999 ). An additional interplay between NFkB and the Cdk/E2F pathway is highlighted by the direct interaction of E2F1 with RelA that antagonized the antiapoptotic activity of NF-kB, by preventing activation of MnSOD (Tanaka et al., 2002) .
While NF-kB is often associated with increased cell proliferation, it can suppress cell proliferation in certain cell types (Abbadie et al., 1993; Seitz et al., 1998; Sheehy and Schlissel, 1999; van Hogerlinden et al., 1999; Bernard et al., 2001c) . For example, the epidermis of mice expressing p50/p65 is hypoplastic, contrary to that of mice expressing a super-repressor IkB in the skin that is hyperplastic (Seitz et al., 1998) . In light of these findings, it will be interesting to unravel the molecular mechanisms that govern the proand antiproliferative actions of NF-kB in different cell types.
Antiapoptotic activity of NF-kB: its implication in cancer and therapy A link between aberrant NF-kB activity and cancer was initially suggested by the acute oncogenicity of its viral oncoprotein v-Rel that causes aggressive lymphomas in animal models (reviewed in Gilmore, 1999) . Since then, constitutive nuclear NF-kB activity has emerged as a hallmark for many human leukemias, lymphomas and solid tumors, most commonly due to persistent activation of the IKK complex (reviewed in Rayet and Gelinas, 1999; . These include Hodgkin's lymphoma, diffuse large B-cell lymphoma (DLBCL), acute lymphoblastic leukemia, chronic myelogenous leukemia, ATL and breast cancer among many others (Bargou et al., 1997; Nakshatri et al., 1997; Sovak et al., 1997; Cogswell et al., 2000; Kordes et al., 2000; Davis et al., 2001; Hinz et al., 2001; Kalaitzidis et al., 2002) . Amplification and overexpression of rel/nf-kB genes is another means by which NF-kB is deregulated in cancer (reviewed in Rayet and Gelinas, 1999) . Moreover, several oncoproteins including Ha-Ras and Bcr-Abl rely on NF-kB to mediate their transforming activity, although recent work showed that NF-kB activation by Ras and Bcr-Abl does not involve IKK (Finco et al., 1997; Mayo et al., 1997; Reuther et al., 1998; Arsura et al., 2000; Hanson et al., 2003) . Since human tumors frequently contain mutations in ras genes, and Bcr-Abl is involved in acute lymphoblastic leukemia and chronic myelogenous leukemia, it is reasonable to expect that activation of these oncogenes in human tumors may be yet another way to activate NF-kB in cancer constitutively.
Lately, studies in primary cell cultures and animal models provided evidence that mammalian NF-kB proteins can have a proactive role in carcinogenesis. MMTV-driven expression of the mouse c-rel gene gave rise to late-onset mammary carcinomas in transgenic mice, whereas retroviral-mediated overexpression of the human or mouse c-rel genes malignantly transformed primary chicken spleen cells that could induce tumors in vivo Fan et al., 2003; RomieuMourez et al., 2003) . Although the exact role of NF-kB in the pathogenesis of human tumors remains to be determined, it is clear that in many instances suppression of apoptosis is an important part of its contribution. Indeed, inhibition of NF-kB sensitizes many tumor cells to death-inducing stimuli, including chemotherapeutic agents (reviewed in Lin and Karin, 2003) . For example, delivery of a recombinant super-repressor IkB to chemoresistant tumors in mouse xenograft models provoked tumor regression by sensitizing them to chemotherapeutic treatment with the topoisomerase I inhibitor CPT-11 (Wang et al., 1999a; Cusack et al., 2000) . Consistent with this work, NF-kB inhibition in many human tumor-derived cell lines, including malignant Reed-Sternberg (H-RS) cells of Hodgkin's disease and DLBCLs, induces spontaneous apoptosis or/and sensitizes them to killing by TNFa or anticancer drugs (Table 2 ; for example, Bargou et al., 1997; Davis et al., 2001) . These results agree with the elevated levels of NF-kB-dependent antiapoptotic proteins observed in many human tumors, including Bfl-1/ A1, c-IAP2, Bcl-xL and Bcl-2. These findings suggest that suppression of NF-kB might enhance the efficacy of anticancer treatments. In this regard, it is tempting to speculate that part of the therapeutic effects of anti-Her-2/neu monoclonal antibodies (Herceptin) used in conjunction with chemotherapy to treat Her-2/neu-positive breast cancers might perhaps derive from suppression of NF-kB's anti-apoptotic effects, as decreased NF-kBbinding activity was observed following treatment of a breast cancer cell line with anti-neu antibodies (Pianetti et al., 2001) . However, the exact role of NF-kB in BcrAbl-induced leukemias remains to be clarified, since its antiapoptotic activity is not necessary for Bcr-Ablmediated cell survival (Reuther et al., 1998) .
Since many chemotherapeutic agents trigger NF-kB activation, hence decreasing their effectiveness, many investigators have sought to characterize the mechanisms involved and to identify compounds that could circumvent this problem (reviewed in Garg and Aggarwal, 2002) . A study by Panta et al. (2003) identified that anthracyclines induce a novel pathway of ATM and DNA-PK signaling, which leads to NF-kB activation and chemoresistance via a MEK/ ERK/p90 rsk cascade. Recently, the same group developed a new class of cytoplasmic-targeted anthracyclines that can provoke apoptosis with improved cytotoxicity and are unaffected by NF-kB-induced antiapoptotic genes . The discovery that IKKmediated NF-kB activation decreases p53 stability brings up another way for NF-kB to counter the efficiency of chemotherapeutic treatment with agents like doxorubicin (Tergaonkar et al., 2002) . Since IkB undergoes ubiquitin-mediated degradation via the proteasome, proteasome inhibitors have been used as an alternative approach to suppress NF-kB in tumor cells. Among them, bortezomib (PS-341; Velcade) is a potent and selective proteasome inhibitor that was shown to sensitize tumor cells to chemotherapy and radiation in preclinical models, for example, in human colorectal cancer cells in a xenograft model (Cusack et al., 2001; reviewed in Lenz, 2003) . PS-341 has since been approved for treatment of multiple myeloma and has shown promising results in early phase clinical trials for lymphoma, prostate cancer and lung cancer (reviewed in Lenz, 2003; Richardson, 2003) . However, since the proteasome is involved in the degradation of many other cellular factors, including cyclins, cyclin-dependent kinase inhibitors p21Waf1 and p27Kip1 and tumor suppressor p53, there is a great deal of interest in the quest for more specific NF-kB inhibitors.
It should be noted that while NF-kB contributes to oncogenesis in a majority of cell types, its IkBamediated suppression in keratinocytes was recently demonstrated to be necessary for Ras-mediated induction of invasive epidermal tumors resembling squamous cell carcinoma (Dajee et al., 2003) . Since NF-kB mediates Ras-induced growth arrest in keratinocytes, antagonizing NF-kB in these cells is required to bypass this roadblock to malignant transformation. It therefore appears that depending on the cell type, NFkB can be viewed as a positive or negative factor for oncogenesis.
Conclusions
It is now clear that in addition to its widely recognized role as a key regulator of immune and inflammatory responses, NF-kB has emerged as a decisive factor in the cell's response to apoptotic challenge. Indeed, over 1800 papers addressing the role of NF-kB in apoptosis were published since the end of 1999 when this topic was last reviewed in Oncogene. As illustrated in this review, the effects of NF-kB on apoptosis has far-reaching consequences for normal development and/or homeostasis in many cells and tissues, including the immune system, hair follicles and epidermal appendages, the liver and the nervous system. NF-kB's implication in apoptosis is also vital to the outcome of viral infections, the onset and progression of many cancers and their response to radiation and chemotherapy. While NF-kB is most commonly found to be cytoprotective, there are a number of instances where it is proapoptotic depending on the inducing stimulus and the cell context. A lot of progress has been made in understanding its mode of action and its interplay with other key factors, including JNK, Arf, p53, p73 and FADD to name a few. These studies identified many anti-and proapoptotic NF-kBregulated genes that mediate its activity, uncovered alternative means by which it functions and unveiled specific protein interactions and pathways that modulate its activity. These important new insights fuel hope that novel approaches will be developed to control the effects of NF-kB on apoptosis. Since deregulated NF-kB activity is a hallmark of many different cancers, efforts to better understand the mechanisms that drive constitutive NF-kB signaling will undoubtedly help the development of new strategies to restrict tumor cell growth and suppress both intrinsic and therapy-induced chemoresistance. These might also be applicable to other disease conditions in which NF-kB is implicated, although serious consideration should be given to circumstances where NF-kB is proapoptotic. The coming years promise to bring significant advances in this quest. In light of its pivotal role in apoptosis, it is clear that for many cells encountering death-inducing stimuli, the answer to the question: 'To be, or not to be' truly is NF-kB.
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